Increasing evidence has suggested that
microRNAs (
miRNAs) are critical regulators of
tumorigenesis. MicroRNA-613 (miR-613) has recently been reported as a novel
tumor-related
miRNA that plays an important role in multiple
cancers. However, the expression and functional significance of miR-613 in
glioma remains unclear. In this study, we aimed to investigate the biological function of miR-613 in
glioma. We found that miR-613 expression was frequently downregulated in
glioma tissues and cell lines compared with normal controls. Overexpression of miR-613 impeded proliferation and colony formation and induced cell cycle arrest in G0/G1 phase, and also inhibited the invasive ability of
glioma cells. By contrast, miR-613 inhibition had the opposite effects. Bioinformatic analysis and dual-
luciferase reporter assays showed that miR-613 directly targets the 3'-untranslated region of
cyclin-dependent kinase 14 (CDK14). Real-time quantitative PCR and Western blot analysis showed that CDK14 expression is negatively regulated by miR-613. In addition, miR-613 expression was inversely correlated with CDK14 expression in clinical
glioma tissues. Moreover, overexpression of miR-613 decreased the
protein expression of β-
catenin and inhibited the activation of Wnt signaling. Importantly, the antitumor effects of miR-613 were significantly reversed by CDK14 overexpression. Overall, our results show that miR-613 inhibits
glioma cell proliferation and invasion by downregulating CDK14, suggesting that miR-613 and CDK14 may serve as potential therapeutic targets for the treatment of
glioma.